Dr. Grazia Piizzi, PhD
Chief Scientific Officer, Juvenescence
I believe we can transform how we prevent and treat age-related diseases, and truly reimagine how we can pursue a long and fulfilling life.
Dr. Grazia Piizzi, PhD, becomes the first Chief Scientific Officer of Juvenescence. She has more than 15 years of experience in the global pharmaceutical and biotech industry. Dr. Piizzi spent 10 years at Novartis Cambridge and Basel leading global teams responsible from target ID to clinical candidate selection across multiple disease areas. Later, she joined Merck Cambridge to build the new Exploratory Science Center (ESC) and worked closely with Merck BD&L and Venture teams. At Merck, Dr. Piizzi established a multidisciplinary team and platform to identify opportunities in infectious diseases, microbiome, and immune-cancer-microbiome interactions.
More recently, Dr. Piizzi was the SVP of Small Molecules R&D and Head of Inflammation at a Flagship Pioneering startup, Cygnal Therapeutics, decoding the links between peripheral neurons and diseases.
Dr. Piizzi received her Ph.D. in Organic Chemistry at UCLA, and subsequently completed her postdoctoral work at MIT on the synthesis and biological properties of natural products.
She currently serves in the NIH SBIR committee to review research and commercialization grants for drug discovery and development.
Dr. Piizzi pursues swimming as her main exercise and enjoys visual arts, reading and traveling in her free time.